Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
jesse-john-francis-clark
Press Release
Sep 3, 2020
Fixx Pharmaceuticals Says Human Embryo Gene Editing Should Wait
Fixx Pharmaceuticals founder, Jesse John Francis Clark, responds to recent report stating that human embryo gene editing isn't safe, yet.
Read More
Press Release
Aug 27, 2020
Fixx Pharmaceuticals Wants to Dominate Hemophilia Market With Gene Editing
Read More
First
Prev
1
Next
Last